| Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 301.03M | 489.79M | 661.23M | 306.56M | 221.89M |
| Gross Profit | 763.00K | 3.25M | 22.12M | 10.18M | 13.90M |
| EBITDA | -30.87M | -16.77M | -4.31M | -19.16M | 4.92M |
| Net Income | -50.03M | -19.94M | -8.83M | -21.01M | 1.01M |
Balance Sheet | |||||
| Total Assets | 380.56M | 291.71M | 273.98M | 253.75M | 149.41M |
| Cash, Cash Equivalents and Short-Term Investments | 39.03M | 23.93M | 153.35M | 139.55M | 30.96M |
| Total Debt | 187.58M | 75.30M | 16.55M | 16.34M | 25.12M |
| Total Liabilities | 277.31M | 137.32M | -49.72M | 108.43M | 31.71M |
| Stockholders Equity | 94.63M | 144.81M | 169.32M | 145.32M | 117.70M |
Cash Flow | |||||
| Free Cash Flow | -90.42M | -125.45M | -18.44M | 72.11M | 2.14M |
| Operating Cash Flow | 17.84M | -56.69M | -17.54M | 74.47M | 2.22M |
| Investing Cash Flow | -108.24M | -90.48M | -907.00K | -2.36M | -85.00K |
| Financing Cash Flow | 105.48M | 24.62M | 33.62M | 35.97M | -11.18M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$1.60B | 5.98 | 7.54% | 8.00% | -9.50% | -24.73% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
50 Neutral | HK$134.60M | -3.32 | -6.59% | ― | 50.50% | 27.48% | |
47 Neutral | HK$96.00M | 2.26 | -10.63% | ― | 1.93% | -158.33% | |
46 Neutral | HK$584.89M | -0.40 | 243.41% | ― | -24.93% | -72.69% | |
42 Neutral | HK$351.09M | -3.32 | -75.76% | ― | -30.47% | -57.80% | |
41 Neutral | HK$94.08M | -4.63 | 476.40% | ― | 4.00% | 13.57% |